Algorae Pharmaceuticals Limited

Algorae Pharmaceuticals Limited - Enterprise Valueverified

LVCLF

Price:

$0.0081

Market Cap:

$17.13M

Algorae Pharmaceuticals Limited, established in 1987 and based in Melbourne, Australia, is a pharmaceutical development company. The firm primarily conducts its research and development in New Zealand, focusing on living cell technologies. Its product pipeline includes several key candidates: AI-116, a novel combination therapy featuring cannabidiol and an existing pharmaceutical ingredient, intended for the treatment of dementia, including Alzheimer's disease; NTCELL, an alginate-coated capsule developed to address Parkinson's disease; and AI-168, another combination drug that combines a cannabinoid with an off-patent pharmaceutical ingredient, aimed at treating cardiovascular conditions li...[Read more]

Industry

Biotechnology

IPO Date

2010-06-01

Stock Exchange

OTC

Ticker

LVCLF

The Enterprise Value as of June 2026 (TTM) for Algorae Pharmaceuticals Limited (LVCLF) is 16.00M

According to Algorae Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 16.00M. This represents a change of 14.80% compared to the average of 13.93M of the last 4 quarters.

Algorae Pharmaceuticals Limited (LVCLF) Historical Enterprise Value (quarterly & annually)

How has LVCLF Enterprise Value performed in the past?

The mean historical Enterprise Value of Algorae Pharmaceuticals Limited over the last ten years is 6.59M. The current 16.00M Enterprise Value has changed 24.17% with respect to the historical average. Over the past ten years (40 quarters), LVCLF's Enterprise Value was at its highest in in the December 2025 quarter at 22.50M. The Enterprise Value was at its lowest in in the June 2020 quarter at -2710218.00.

Quarterly (TTM)
Annual

Average

6.59M

Median

6.22M

Minimum

1.05M

Maximum

15.19M

Algorae Pharmaceuticals Limited (LVCLF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Algorae Pharmaceuticals Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 143.54%

Maximum Annual Enterprise Value = 15.19M

Minimum Annual Increase = -47.53%

Minimum Annual Enterprise Value = 1.05M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20257.97M-47.53%
202415.19M7.92%
202314.07M132.21%
20226.06M-19.35%
20217.51M17.91%
20206.37M52.65%
20194.17M143.54%
20181.71M63.91%
20171.05M-42.35%
20161.81M44.37%

Algorae Pharmaceuticals Limited (LVCLF) Average Enterprise Value

How has LVCLF Enterprise Value performed in the past?

The current Enterprise Value of Algorae Pharmaceuticals Limited (LVCLF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

12.41M

5-year avg

10.16M

10-year avg

6.59M

Algorae Pharmaceuticals Limited (LVCLF) Enterprise Value vs. Peers

How is LVCLF’s Enterprise Value compared to its peers?

Algorae Pharmaceuticals Limited’s Enterprise Value is greater than HOOKIPA Pharma Inc. (-19288217.00), greater than Oxford BioDynamics Plc (7.23M), less than Devonian Health Group Inc. (40.82M), less than EOM Pharmaceuticals Holdings, Inc. (25.52M), greater than Nymox Pharmaceutical Corporation (11.27M), greater than Hemostemix Inc. (13.33M), greater than Sirona Biochem Corp. (3.93M), greater than LianBio (2.73M), less than Valeo Pharma Inc. (57.68M), greater than Propanc Biopharma, Inc. (2.42M),

Build a custom stock screener for Algorae Pharmaceuticals Limited (LVCLF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Algorae Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Algorae Pharmaceuticals Limited (LVCLF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Algorae Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Algorae Pharmaceuticals Limited's Enterprise Value?

What is the highest Enterprise Value for Algorae Pharmaceuticals Limited (LVCLF)?

What is the 3-year average Enterprise Value for Algorae Pharmaceuticals Limited (LVCLF)?

What is the 5-year average Enterprise Value for Algorae Pharmaceuticals Limited (LVCLF)?

How does the current Enterprise Value for Algorae Pharmaceuticals Limited (LVCLF) compare to its historical average?